Lyme disease typically presents in three
distinct stages. Each stage is characterized by different signs and
symptoms.
Stage One - Early Localized
Infection
Stage one disease symptoms occur within 1-30
days after being bitten by the deer tick, Ixodes Scapularis or
Ixodes Pacificus. In this stage the pathogen, Borrelia
burgdorferi, begins replicating in tissues adjacent to the site of
initial infection.
|
Erythema Migrans
(EM) |
Signs and symptoms include:
- Erythema Migrans
- Myalgia
- Arthalgia
- Headache
- Fever
- Nucal Rigidity
Erythema Migrans (EM) is the most common
symptom, occurring in as many as 75% of patients.
It is considered pathognomonic for Lyme
Disease. Lesions are circular and reddish, usually neither raised or nor
pruritic. The size varies from quite small (1 cm) to up to 70 cm in
diameter. Central clearing and "bulls-eye" formation occurs less than half
the time. The rash can occur either at the site of the bite, as seen in
20% of patients, or at a site secondary to it [10].
The other symptoms (myalgia, arthalgia,
headache, and fever) are non-specific for Lyme Disease infection and occur
in 50% of infected patients. Nucal rigidity occurs in less than 50% of
patients [11].
Stage 2 – Early Disseminated Lyme
Disease
Stage two disease occurs within weeks to
months of the bite as the Borrelia move in the blood stream from the site
of infection to more distant tissues and organs. In this stage,
neurological, cardiovascular, and arthritic symptoms emerge. At this stage
symptoms usually involve the peripheral but not central nervous system.
Signs and symptoms include:
- Menigitis (photophobia, phonophobia, nucal rigidity)
- Cranial neuropathy
- Intermittent inflammatory arthritis
Menigitis is a one of the most common
symptoms of Stage Two Lyme Disease. Neuropathies often effect the seventh
cranial nerve and cause facial palsies, especially in children, and may be
bilateral. Arthritis occurs in about 20% of patients and usually involves
the knee joint [12].
Stage 3 – Chronic Lyme Disease
Stage Three, or Chronic Lyme Disease, can
occur from months to years after the tick bite. Infection of the central
nervous system causes more severe neurological symptoms. Stage three
symptoms can disappear for months or years at a time.
Symptoms include:
- Rheumatoid Arthritis
- Atrioventricular conduction abnormalities (AV heart block)
- Encephalopathy
- Decreased memory
- Sleep Disturbances
- Mood changes
- Ataxia
- Depression
- Anxiety
Rheumatoid Arthritis (RA) is the most common
symptom at this stage and occurs in almost 80% of patients. Psychological
effects, due to encephalopathy and other pathologies, are also very
common. Depression, memory loss, and anxiety are the most common. AV block
is intermittent and usually resolves spontaneously and does not require
pacemaker implantation [13].
DIAGNOSTIC TESTS
Lyme disease is diagnosed in a
symptomatic patient using a variety of serological tests. Indirect ELISA testing for Lyme specific antibodies in serum
is the most common test for Lyme Disease. By 6-8 weeks after infection,
most symptomatic patients (96%) exhibit detectable levels of anti-Lyme
IgM. False positives can be caused by infection with several other
diseases including Rocky Mountain Spotted Fever, syphilis, lupus, and
rheumatoid arthritis. Serum IgG levels require longer (4-6 months) to peak
than IgM, but are more specific for Lyme. Both IgM and IgG levels remain
high long after initial infection even if the disease is absent. IgG titer
can remain high indefinitely after exposure. Early treatment of the
disease using antibiotics lowers the serum titer of anti-Lyme antibodies
and may contributes to the high (32%) false negative rate of these tests.
Western Blots and IFA (immunofluorescence assays) are used to confirm
positive ELISA tests. [14,15]
CSF cultures obtained by LP (lumbar
puncture) are used to confirm Lyme as the cause of meningitis. This test
is only positive in 10% of patients with Lyme disease. Some work has been
done using PCR (polymerase chain reaction) to detect Borrelia in serum or
CSF, though this remains experimental at this time. Lyme urine antigen
testing and BAT (borrelacidal antibody testing) are also unproven and are
largely experimental. |